Jane Street
TXMD icon

Jane Street’s TherapeuticsMD TXMD Stock Holding History

Jane Street’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-382
Closed -$7K – 10918
2022
Q1 		$7K Sell
382
-5,492
-93% -$86.4K ﹤0.01% 10108
2021
Q4 		$104K Sell
5,874
-266
-4% -$7.97K ﹤0.01% 9233
2021
Q3 		$228K Buy
6,140
+1,606
+35% +$71.3K ﹤0.01% 8660
2021
Q2 		$269K Sell
4,534
-351
-7% -$21.3K ﹤0.01% 8342
2021
Q1 		$327K Buy
4,885
+4,176
+589% +$327K ﹤0.01% 7559
2020
Q4 		$42K Sell
709
-3
-0.4% -$205 ﹤0.01% 7336
2020
Q3 		$56K Sell
712
-2,080
-74% -$166K ﹤0.01% 6895
2020
Q2 		$175K Buy
+2,792
New +$163K ﹤0.01% 6453
2020
Q1 		– Sell
-1,563
Closed -$189K – 5999
2019
Q4 		$189K Buy
+1,563
New +$225K ﹤0.01% 4736
2019
Q3 		– Sell
-2,412
Closed -$314K – 5770
2019
Q2 		$314K Buy
2,412
+1,206
+100% +$216K ﹤0.01% 4141
2019
Q1 		$294K Sell
1,206
-940
-44% -$249K ﹤0.01% 4271
2018
Q4 		$409K Buy
2,146
+585
+37% +$143K ﹤0.01% 3687
2018
Q3 		$512K Buy
+1,561
New +$478K ﹤0.01% 3592
2018
Q1 		– Sell
-1,743
Closed -$526K – 5414
2017
Q4 		$526K Buy
1,743
+1,205
+224% +$335K ﹤0.01% 3114
2017
Q3 		$142K Sell
538
-397
-42% -$115K ﹤0.01% 4218
2017
Q2 		$246K Buy
+935
New +$234K ﹤0.01% 3812
2017
Q1 		– Sell
-358
Closed -$103K – 4703
2016
Q4 		$103K Buy
+358
New +$111K ﹤0.01% 3866
2016
Q1 		– Sell
-781
Closed -$405K – 4663
2015
Q4 		$405K Buy
+781
New +$288K ﹤0.01% 2736
2014
Q3 		– Sell
-204
Closed -$45K – 3064
2014
Q2 		$45K Sell
204
-172
-46% -$38.3K ﹤0.01% 2436
2014
Q1 		$119K Buy
+376
New +$120K ﹤0.01% 2484

Other funds holding TXMD

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $273M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jane Street's TXMD Position: Q2 2022 in Review

Jane Street sold out of TherapeuticsMD (TXMD) in Q2 2022, closing a stake of 382 shares — an estimated $7K sold.

Jane Street first reported a position in TXMD in Q1 2014 and held it in 20 quarters. The position peaked at $526K in Q4 2017. 53 funds tracked by Wall St. Rank hold TXMD as of Q2 2022.

  • Jane Street reported no remaining TherapeuticsMD position as of Q2 2022 after selling out during the quarter.
  • Jane Street sold 382 TherapeuticsMD shares in Q2 2022, an estimated $7K.
  • Jane Street first reported a position in TherapeuticsMD in Q1 2014 and held it in 20 quarters.
  • Jane Street's TherapeuticsMD position peaked at $526K in Q4 2017.
  • 53 funds tracked by Wall St. Rank held TherapeuticsMD as of Q2 2022.

Based on Jane Street's 13F filing for Q2 2022, filed 16 Aug 2022.